Furoscix FDA Approval Status
Last updated by Judith Stewart, BPharm on July 6, 2020.
FDA Approved: No
Brand name: Furoscix
Generic name: furosemide
Company: scPharmaceuticals, Inc.
Treatment for: Heart Failure
Furoscix (furosemide) is a subcutaneous formulation of the approved diuretic furosemide delivered via a wearable, pre-programmed on-body drug delivery system. Furoscix is in development for treatment of congestion in patients with heart failure, and has the potential to provide an outpatient alternative for the treatment of worsening heart failure due to congestion.
Development timeline for Furoscix
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.